Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NMNAT1 pseudogene 2 (NMNAT1P2) is a non-coding pseudogene related to the NMNAT1 gene, which encodes nicotinamide nucleotide adenylyltransferase 1, a nuclear enzyme essential for NAD+ synthesis[5]. Pseudogenes like NMNAT1P2 do not encode functional protein products, are not currently considered therapeutic or biological targets, and are not associated with known disease mechanisms or drug actions. NMNAT1 pseudogenes, including NMNAT1P2, may be identified in genomic surveys but have no established biological, diagnostic, or therapeutic roles. The information relevant to human health and disease pertains to the functional NMNAT1 gene, not its pseudogenes[5].
None (No drugs target this pseudogene, so no mechanism of action applies.)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NMNAT1 pseudogene 2 (NMNAT1P2).